Insider · CIK 0001166288
Hoffman Robert E.
Reports to the SEC for 11 companies · ANN ARBOR, MI
Transactions
50
Companies
11
Filings
16
CIK
0001166288
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-07-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-07-13 | ESPREsperion Therapeutics, Inc.D Disposition to Issuer | — |
| 2026-06-23 | FBLGFibroBiologics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-28 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2026-03-20 | CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award | — |
| 2026-02-12 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2025-06-12 | FBLGFibroBiologics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-29 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2025-05-29 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-15 | CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award | — |
| 2025-04-01 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-01-02 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2024-08-27 | FBLGFibroBiologics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-08-30 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2023-06-01 | HURATuHURA Biosciences, Inc./NVA Award | — |
| 2022-08-01 | HURATuHURA Biosciences, Inc./NVA Award | — |
| 2022-08-01 | HURATuHURA Biosciences, Inc./NV · Option (right to buy)A Award | — |
| 2022-02-15 | HURATuHURA Biosciences, Inc./NVP Purchase | +$25.8K |
| 2021-11-08 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2021-09-22 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2021-06-22 | KURAKura Oncology, Inc. · Option to purchase common stockA Award | — |
| 2020-09-15 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2020-06-26 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2020-06-24 | KURAKura Oncology, Inc. · Option to purchase common stockA Award | — |
| 2019-12-19 | HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award | — |
| 2019-09-12 | Aravive, Inc.Stock OptionA Award | — |
| 2019-09-05 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2019-09-05 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2019-06-25 | KURAKura Oncology, Inc. · Option to purchase common stockA Award | — |
| 2019-04-30 | HURATuHURA Biosciences, Inc./NV · Performance Stock UnitsD Disposition to Issuer | — |
| 2019-01-03 | Aravive, Inc.Stock OptionA Award | — |
| 2019-01-03 | Aravive, Inc.Stock OptionA Award | — |
| 2019-01-03 | Aravive, Inc.Stock OptionA Award | — |
| 2019-01-03 | Aravive, Inc.Stock OptionA Award | — |
| 2018-12-15 | HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award | — |
| 2018-11-08 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2018-07-02 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$41.1K |
| 2018-07-02 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$1.1M |
| 2018-07-02 | HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion | +$459K |
| 2018-07-02 | HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2018-06-07 | KURAKura Oncology, Inc. · Option to purchase common stockA Award | — |
| 2018-04-30 | HRTXHERON THERAPEUTICS, INC. /DE/J Other | +$9,833.82 |
| 2018-04-13 | HURATuHURA Biosciences, Inc./NV · Performance Stock UnitsA Award | — |
| 2018-04-13 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2017-12-18 | HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award | — |
| 2017-11-14 | CombiMatrix CorpWarrant (Right to Buy)U Disposition from Tender | — |
| 2017-11-14 | CombiMatrix CorpU Disposition from Tender | — |
| 2017-11-14 | CombiMatrix CorpD Disposition to Issuer | — |
| 2017-10-31 | HRTXHERON THERAPEUTICS, INC. /DE/J Other | +$6,993.46 |
Recent filings
- 4Hoffman Robert E.0001628280-26-048014SEC(opens sec.gov)
- 4Hoffman Robert E.0001493152-26-029851SEC(opens sec.gov)
- 4Hoffman Robert E.0001628280-26-039525SEC(opens sec.gov)
- 4Hoffman Robert E.0001104659-26-033958SEC(opens sec.gov)
- 4Hoffman Robert E.0000897069-26-000360SEC(opens sec.gov)
- 4Hoffman Robert E.0001641172-25-014934SEC(opens sec.gov)
- 4Hoffman Robert E.0001628280-25-028828SEC(opens sec.gov)
- 4Hoffman Robert E.0001104659-25-052122SEC(opens sec.gov)
- 4Hoffman Robert E.0001628280-25-016196SEC(opens sec.gov)
- 4Hoffman Robert E.0000897069-25-000037SEC(opens sec.gov)
- 4Hoffman Robert E.0001493152-24-034068SEC(opens sec.gov)
- 4Hoffman Robert E.0001493152-23-031537SEC(opens sec.gov)
- 4Hoffman Robert E.0001493152-23-019950SEC(opens sec.gov)
- 4Hoffman Robert E.0001493152-22-021170SEC(opens sec.gov)
- 4Hoffman Robert E.0000905718-22-000393SEC(opens sec.gov)
- 4HOFFMAN ROBERT0000899243-21-043913SEC(opens sec.gov)
Companies
- Aravive, Inc.Former Director
- ARENA PHARMACEUTICALS INCSVP, Finance and CFO
- CombiMatrix CorpDirector
- CytoDyn Inc.Chief Financial OfficerCYDY
- Esperion Therapeutics, Inc.DirectorESPR
- FibroBiologics, Inc.DirectorFBLG
- HERON THERAPEUTICS, INC. /DE/CFO & SVP, FinanceHRTX
- INNOVUS PHARMACEUTICALS, INC.CHIEF FINANCIAL OFFICER
- Kura Oncology, Inc.DirectorKURA
- MABVAX THERAPEUTICS HOLDINGS, INC.Director
- TuHURA Biosciences, Inc./NVDirectorHURA
Address
C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI, 48108